Suchergebnisse - (Subject:"Immunologic Factors")

PubPharm (222)

41

How I manage the toxicities of myeloma drugs

enthalten in: Blood | 2017

von Delforge, M. | Ludwig, H.

42

A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis

enthalten in: Blood | 2017

von Palladini, G. | Milani, P. | Foli, A. | +4

43

p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma

enthalten in: Blood | 2017

von Hideshima, T. | Cottini, F. | Nozawa, Y. | +13

44

Complement factors (H) into thrombosis

enthalten in: Blood | 2017

von Holinstat, M.

CommentOn: Blood. 2017 Mar 2;129(9):1184-1196. - PMID 28057640

45

Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity

enthalten in: Blood | 2017

von Sebastian, S. | Zhu, Y. | Braggio, E. | +8

CommentIn: Blood. 2017 Feb 23;129(8):923-925. - PMID 28232622

46

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

enthalten in: Blood | 2016

von Cheson, B. | Ansell, S. | Schwartz, L. | +6

CommentIn: Blood. 2016 Nov 24;128(21):2481-2482. - PMID 27884831

47

How I treat refractory immune thrombocytopenia

enthalten in: Blood | 2016

von Cuker, A. | Neunert, C.

CommentIn: Blood. 2016 Sep 22;128(12):1537-8. - PMID 27658695

48

Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura

enthalten in: Blood | 2016

von Page, E. | Kremer Hovinga, J. | Terrell, D. | +2

CommentIn: Blood. 2016 Jun 16;127(24):2952-3. - PMID 27313327

49

Follicular lymphoma : evolving therapeutic strategies

enthalten in: Blood | 2016

von Kahl, B. | Yang, D.

50

Influence of immunoglobulin isotype on therapeutic antibody function

enthalten in: Blood | 2016

von Beers, S. | Glennie, M. | White, A.